The latest research from Fore Pharma, Japan Myocardial Infarction Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Myocardial Infarction pipeline products, Myocardial Infarction epidemiology, Myocardial Infarction market valuations and forecast, Myocardial Infarction products sales and competitive landscape in Japan.
The research is classified into nine sections – Myocardial Infarction overview including etiology, pathophysiology, and diagnosis, Myocardial Infarction treatment options, Myocardial Infarction pipeline products, Myocardial Infarction market analysis comprising of Myocardial Infarction epidemiology, key products marketed for Myocardial Infarction, market valuations and forecast, products sales and market shares.
Research Scope: - Myocardial Infarction Pipeline: Find out the products in clinical trials for the treatment of Myocardial Infarction by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Myocardial Infarction Epidemiology: Find out the number of patients diagnosed (prevalence) with Myocardial Infarction in Japan - Myocardial Infarction Products: Identify key products marketed and prescribed for Myocardial Infarction in Japan, including trade name, molecule name, and company - Myocardial Infarction Product Sales: Find out the sales revenues of Myocardial Infarction products, both branded and generics, in Japan - Myocardial Infarction Market Valuations: Find out the market size for Myocardial Infarction products in 2015 in Japan. Find out how the market advanced from 2010 and forecast to 2020 - Myocardial Infarction Products Market Share: Find out the market shares for key Myocardial Infarction products in Japan
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Myocardial Infarction market analysis and sales trends - Track competitor drugs sales and market share in Japan Myocardial Infarction market - Track competitive developments in Myocardial Infarction market and present key issues and learnings - Synthesize insights for Myocardial Infarction market and products to drive business performance - Answer key business questions about the Myocardial Infarction market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Myocardial Infarction products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
KEY FINDINGS The Asia-Pacific peripheral vascular devices market is anticipated to record a CAGR of 11.98% during the forecast period, 2021-2028. The rising prevalence of chronic diseases and the increasing disposable incomes are among the factors that contribute to the market growth. MARKET INSIGHTS India,...
‘Chronic kidney disease (CKD)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Chronic kidney disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
Chronic Kidney Disease (CKD) Understanding
Coca-Cola Plus: Success Case Study
Coca-Cola Plus: Success Case Study, a Food for Specified Health Uses (FOSHU) beverage, in Japan underlines the growing demand for functional beverages in the country.
In 2017, Coca-Cola rolled out a Food for Specified Health Uses (FOSHU)-certified...
Galacto?oligosaccharides (GOS) Market Size, Share & Trends Analysis Report By Application (Food & Beverages, Dietary Supplements), By Region, And Segment Forecasts, 2019 - 2025 The global galacto-oligosaccharides (gos) market size is projected to reach USD 1.58 billion by 2025. It is expected to expand at a CAGR of...
Guidewires Market Size, Share & Trends Analysis Report By Product (Coronary, Peripheral, Urology, Neurovascular), By Coatings (Coated, Non Coated), By Raw Material, And Segment Forecasts, 2019 - 2025
The global guidewires market size is expected to reach USD 2.90 billion by 2025, at a CAGR 6.3% over a forecast period....
Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders.Its lead product candidate vadadustat is a HIF-PH inhibitor, a regulator...
123 pages •
By Prescient & Strategic Intelligence Private Limited
• Jun 2018
Global PoCUS device market is expected to reach $3.1 million by 2025, The market is mainly driven by surge in geriatric population, increasing prevalence of chronic diseases, technological advancements in PoCUS devices, increasing awareness about the benefits of portable ultrasound devices, and rising healthcare expenditure. Insights...
Gross Domestic Product
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.